These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29391893)

  • 1. Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomy.
    Kamei R; Yoshimura K; Yoshino S; Inoue M; Asao T; Fuse M; Wada S; Kuramasu A; Furuya-Kondo T; Oga A; Iizuka N; Suzuki N; Maeda N; Watanabe Y; Matsukuma S; Iida M; Takeda S; Ueno T; Yamamoto N; Fukagawa T; Katai H; Sasaki H; Hazama S; Oka M; Nagano H
    Oncol Lett; 2018 Jan; 15(1):747-754. PubMed ID: 29391893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of Natural Killer Group 2D Receptor Expression and That of Its Ligand in Ovarian Carcinomas: A Retrospective Study.
    Lee GH; An HJ; Kim TH; Kim G; Park KS; Park H; Lee TH; Kwon AY
    Yonsei Med J; 2021 Apr; 62(4):288-297. PubMed ID: 33779082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
    Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
    J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence.
    Kamimura H; Yamagiwa S; Tsuchiya A; Takamura M; Matsuda Y; Ohkoshi S; Inoue M; Wakai T; Shirai Y; Nomoto M; Aoyagi Y
    J Hepatol; 2012 Feb; 56(2):381-8. PubMed ID: 21756848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome regulation of ULBP1 transcription.
    Butler JE; Moore MB; Presnell SR; Chan HW; Chalupny NJ; Lutz CT
    J Immunol; 2009 May; 182(10):6600-9. PubMed ID: 19414815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer.
    Okita R; Maeda A; Shimizu K; Nojima Y; Saisho S; Nakata M
    Oncotarget; 2019 Nov; 10(63):6805-6815. PubMed ID: 31827723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer.
    Cho H; Chung JY; Kim S; Braunschweig T; Kang TH; Kim J; Chung EJ; Hewitt SM; Kim JH
    BMC Cancer; 2014 Dec; 14():957. PubMed ID: 25510288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.
    Dunn C; Chalupny NJ; Sutherland CL; Dosch S; Sivakumar PV; Johnson DC; Cosman D
    J Exp Med; 2003 Jun; 197(11):1427-39. PubMed ID: 12782710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
    Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
    Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to natural killer cell-mediated lysis of colon cancer cells is enhanced by treatment with epidermal growth factor receptor inhibitors through UL16-binding protein-1 induction.
    Bae JH; Kim SJ; Kim MJ; Oh SO; Chung JS; Kim SH; Kang CD
    Cancer Sci; 2012 Jan; 103(1):7-16. PubMed ID: 21951556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells
    Wang Z; Wang Z; Li S; Li B; Sun L; Li H; Lin P; Wang S; Teng W; Zhou X; Ye Z
    Front Immunol; 2018; 9():1239. PubMed ID: 29910819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.
    Xuan XY; Zhang JF; Hu GM; Li QR; Liu PP; Du Y
    Cancer Gene Ther; 2015 Jul; 22(7):368-74. PubMed ID: 26113176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ULBP1 is induced by hepatitis C virus infection and is the target of the NK cell-mediated innate immune response in human hepatocytes.
    Dansako H; Imai H; Ueda Y; Satoh S; Wakita T; Kato N
    FEBS Open Bio; 2018 Mar; 8(3):361-371. PubMed ID: 29511613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cells.
    Gowen BG; Chim B; Marceau CD; Greene TT; Burr P; Gonzalez JR; Hesser CR; Dietzen PA; Russell T; Iannello A; Coscoy L; Sentman CL; Carette JE; Muljo SA; Raulet DH
    Elife; 2015 Nov; 4():. PubMed ID: 26565589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8
    Vadstrup K; Galsgaard ED; Jensen H; Lanier LL; Ryan JC; Chen SY; Nolan GP; Vester-Andersen MK; Pedersen JS; Gerwien J; Jensen T; Bendtsen F
    Exp Mol Pathol; 2017 Aug; 103(1):56-70. PubMed ID: 28684217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.
    Shiraishi K; Mimura K; Kua LF; Koh V; Siang LK; Nakajima S; Fujii H; Shabbir A; Yong WP; So J; Takenoshita S; Kono K
    J Gastroenterol; 2016 Dec; 51(12):1101-1111. PubMed ID: 27002316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.
    Zhang X; Rao A; Sette P; Deibert C; Pomerantz A; Kim WJ; Kohanbash G; Chang Y; Park Y; Engh J; Choi J; Chan T; Okada H; Lotze M; Grandi P; Amankulor N
    Neuro Oncol; 2016 Oct; 18(10):1402-12. PubMed ID: 27116977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy.
    Park MJ; Bae JH; Chung JS; Kim SH; Kang CD
    Immunol Invest; 2011; 40(4):367-82. PubMed ID: 21314289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble UL16-binding protein 2 is associated with a poor prognosis in pancreatic cancer patients.
    Kegasawa T; Tatsumi T; Yoshioka T; Suda T; Ikezawa K; Nakabori T; Yamada R; Kodama T; Shigekawa M; Hikita H; Sakamori R; Takehara T
    Biochem Biophys Res Commun; 2019 Sep; 517(1):84-88. PubMed ID: 31303272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis.
    Ruan GT; Xie HL; Zhu LC; Ge YZ; Yan L; Liao C; Gong YZ; Shi HP
    Front Genet; 2022; 13():762514. PubMed ID: 35211154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.